Date: 2015-07-13
Type of information: Resignation
Compound:
Company: Atyr Pharma (USA - CA)
Therapeutic area: Rare diseases
Type agreement: resignation
Action mechanism:
Disease:
Details: * On July 13, 2015, aTyr Pharma, a biotherapeutics company engaged in the discovery and development of Physiocrine-based therapeutics to address severe rare diseases, announced the resignation of President and Chief Operating Officer Frederic Chereau to pursue other opportunities, effective immediately.
Financial terms:
Latest news:
